Apyx Medical

APYX · NASDAQ

$2.44+$0.02 (+0.83%)TodayMarket closed ·
Prev close $2.42

About APYX

Apyx Medical Corp. operates as an energy-based medical technology company. The company is headquartered in Clearwater, Florida and currently employs 205 full-time employees. Its segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment’s product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. The company focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment, designs, develops and manufactures electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs.

Employees
205
Headquarters
Clearwater, Florida
Listed
Jul 22, 1983
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

Apyx Medical executives
NameTitleSince
Stavros Vizirgianakis——
Charles Goodwin—2017
Matthew Hill——
Shawn Roman——
Moshe Citronowicz——
Lawrence Waldman——
Minnie Baylor-Henry——
Wendy Levine——

Revenue by product and region

Fiscal year ended Dec 31, 2023: $52.35M total revenue

By region

  • Domestic$38.34M73.2%
  • International$14.00M26.8%

Similar companies

Companies in the same industry as Apyx Medical

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.